Abmart is the world-wide cost and quality leader in monoclonal antibody development.

The Abmart difference:
1. One of the largest monoclonal antibody production capabilities in the world (over 5000 monoclonal antibodies per year)
2. Proprietary, superior monoclonal antibody technology:
I. Short development time: From gene to antibody in 100 days
Ii. Large library size: 10s to 100s monoclonal hybridoma cell lines for each target
Iii. Targeting multiple epitopes: Cell lines for > 5 independent protein surface epitopes
Iv. High affinity: Kd in the nM range (< 10-8M)
V. Desired isotypes: IgG antibodies
Vi. Capable of developing successful antibodies for difficult protein classes such as GPCR, ion channels and transcription factors
3. Industry's first "Application Guaranteed" antibody offer: Antibodies are guaranteed to work in endogenous applications including WB, IF/ICC, IP, IHC
4. The most competitive pricing: Only $2970 for a custom monoclonal antibody project guaranteed for endogenous WB application
5. Antibodies developed by Abmart have LED to many important